PARP Inhibitors CD Protein Inhibitors Immune Checkpoint Inhibitors Immunotherapy Tyrosine Kinase Inhibitors Other PI3 Kinase Inhibitors | Prostate Cancer | HER2 Negative Breast Cancer | Ovarian Cancer | Colorectal Cancer |
---|---|---|---|---|
rucaparib | ||||
talazoparib | ||||
rucaparib + copanlisib | ||||
niraparib | ||||
PARP inhibitor | ||||
sintilimab + fruquintinib |